Skip to content
Screener

Upstream Bio, Inc. UPB Asset turnover

Asset turnover at other companies

Amgen logo
AmgenAMGN
0.4×0.0×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
0.4×0.0×
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
0×-0.1×
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
0×0.0×
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
0.6×+0.3×
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
0×-0.1×

Other financials

Income statement

See full
Revenue$773.0K-17.5%
Operating income-$42.4M+4.5%
Net income-$39.7M+0.7%
EPS (diluted)-$0.73+1.4%

Balance sheet

See full
Cash & equivalents$79.4M+74.7%
Total debt$954.0K-38.9%
Total equity$271.0M-33.7%
Total assets$281.2M-33.1%

Cash flow

See full
Operating cash flow-$35.6M+9.2%
CapEx$54.0K-70.8%
Free cash flow-$30.7M-55.0%

Valuation

See full
Market cap$404.88M-54.7%
Enterprise value$326.44M-61.6%
P/S128.2×-200×

Profitability

See full
Operating margin-5,382.6%+1,393pp
Net margin-4,955.7%+2,041pp

Returns & leverage

See full
Return on equity-46%—
Debt / equity0×0.0×
Current ratio28×-10.3×

Where this comes from

Calculated from Upstream Bio, Inc.’s reported figures.

total revenue/total assets=0×

Based on trailing twelve months.

The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026. Open the filing →

Filed
Aug 11, 2026, 7:10 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-343417

FAQ

What is Upstream Bio, Inc.'s asset turnover?
Upstream Bio, Inc. (UPB) reported asset turnover of 0× in Q2 2026.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Ask your AI about Upstream Bio, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude